BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,727,947 | -20.5% | 1,091,518 | -20.9% | 0.00% | 0.0% |
Q2 2023 | $9,719,832 | -68.2% | 1,380,658 | -62.3% | 0.00% | -66.7% |
Q1 2023 | $30,518,836 | +169.4% | 3,659,333 | +270.8% | 0.00% | +200.0% |
Q4 2022 | $11,328,429 | +5.2% | 986,797 | +15.4% | 0.00% | 0.0% |
Q3 2022 | $10,770,000 | +33.5% | 854,881 | +12.1% | 0.00% | 0.0% |
Q2 2022 | $8,066,000 | -37.7% | 762,435 | -4.3% | 0.00% | 0.0% |
Q1 2022 | $12,950,000 | +162.1% | 796,441 | +123.3% | 0.00% | – |
Q4 2021 | $4,940,000 | -45.1% | 356,684 | -43.0% | 0.00% | -100.0% |
Q3 2021 | $8,990,000 | -46.9% | 625,644 | -41.5% | 0.00% | -50.0% |
Q2 2021 | $16,917,000 | +23.3% | 1,070,128 | -20.7% | 0.00% | 0.0% |
Q1 2021 | $13,721,000 | +153.8% | 1,349,133 | +85.9% | 0.00% | +100.0% |
Q4 2020 | $5,407,000 | +83.2% | 725,859 | -15.5% | 0.00% | – |
Q3 2020 | $2,952,000 | -65.4% | 859,499 | -52.0% | 0.00% | -100.0% |
Q2 2020 | $8,537,000 | +544.8% | 1,791,548 | +170.8% | 0.00% | – |
Q1 2020 | $1,324,000 | +1.9% | 661,552 | +75.7% | 0.00% | – |
Q4 2019 | $1,299,000 | +351.0% | 376,501 | +273.7% | 0.00% | – |
Q3 2019 | $288,000 | -82.0% | 100,748 | -76.1% | 0.00% | – |
Q2 2019 | $1,599,000 | -18.6% | 421,933 | +74.8% | 0.00% | – |
Q1 2019 | $1,965,000 | +466.3% | 241,372 | +461.4% | 0.00% | – |
Q4 2018 | $347,000 | +39.9% | 42,997 | +32.5% | 0.00% | – |
Q3 2018 | $248,000 | -62.8% | 32,451 | -72.1% | 0.00% | – |
Q2 2018 | $666,000 | +157.1% | 116,231 | +114.2% | 0.00% | – |
Q1 2018 | $259,000 | -10.4% | 54,271 | -7.9% | 0.00% | – |
Q4 2017 | $289,000 | +109.4% | 58,942 | +124.3% | 0.00% | – |
Q3 2017 | $138,000 | +55.1% | 26,274 | +63.9% | 0.00% | – |
Q2 2017 | $89,000 | -57.6% | 16,034 | -35.9% | 0.00% | – |
Q1 2017 | $210,000 | +89.2% | 25,029 | +43.3% | 0.00% | – |
Q4 2016 | $111,000 | +164.3% | 17,461 | +80.9% | 0.00% | – |
Q3 2016 | $42,000 | -6.7% | 9,651 | -39.5% | 0.00% | – |
Q2 2016 | $45,000 | +181.2% | 15,945 | +189.9% | 0.00% | – |
Q1 2016 | $16,000 | -93.1% | 5,500 | -75.5% | 0.00% | – |
Q4 2015 | $232,000 | -64.7% | 22,485 | -61.0% | 0.00% | – |
Q3 2015 | $657,000 | -82.3% | 57,592 | -76.9% | 0.00% | -100.0% |
Q2 2015 | $3,716,000 | +729.5% | 248,874 | +400.8% | 0.00% | – |
Q1 2015 | $448,000 | -24.7% | 49,691 | +1.7% | 0.00% | – |
Q4 2014 | $595,000 | +114.8% | 48,868 | +72.7% | 0.00% | – |
Q3 2014 | $277,000 | -76.7% | 28,299 | -69.6% | 0.00% | – |
Q2 2014 | $1,188,000 | +33.2% | 93,179 | +10.5% | 0.00% | – |
Q1 2014 | $892,000 | +22.9% | 84,300 | -11.7% | 0.00% | – |
Q4 2013 | $726,000 | +18.2% | 95,516 | +13.2% | 0.00% | – |
Q3 2013 | $614,000 | +118.5% | 84,345 | -53.5% | 0.00% | – |
Q2 2013 | $281,000 | – | 181,245 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |